Trials / Completed
CompletedNCT03184402
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study (PART 2)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1252 | tablet |
| DRUG | Gasmotin | tablet |
| DRUG | Placebo of Gasmotin | tablet |
| DRUG | Placebo of DWJ1252 | tablet |
Timeline
- Start date
- 2017-04-24
- Primary completion
- 2017-07-31
- Completion
- 2017-07-31
- First posted
- 2017-06-12
- Last updated
- 2019-06-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03184402. Inclusion in this directory is not an endorsement.